SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Bradpalm1 who wrote (3771)5/1/1998 6:46:00 PM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
Hi, Bradpalm1: I have a copy of the poster/bulletin that will be appearing at the AUA. I don't actually understand, and perhaps someone will clarify with facts (yes, miracles can happen), the presentation. What I've been told is that there is no presentation and no full paper being delivered. Instead people walk around and read these posters! They are fairly short summaries of studies.

I counnted 9 of them on VIVUS's product, mostly quite negative, and just three on Viagra, and one on Vasomax. There are also ones on other products and studies to try to compare some products.

Evidentally there is no opportunity for discussion or questions. I hope my information is incorrect about this, but my read of the "presentation" on Vasomax raises the same questions we've been asking and doesn't answer any at all.

I'll type it out, or most of it, when I have a little more time.

I've been told by a broker that before Viagra was approved that detailed studies were available, that he got reams of material from them, like what is available on their web site now. But he can't get copies of the Vasomax studies, only basically what is in the press releasees.

The source of the information I've posted was in recent press and also in Zonagen press releases, and also is regurgitated in this poster material offered by Dr. Goldstein. There is no indication of Dr. Irwin Goldstein's relationship to Zonagen or to the studies themselves. Does anyone know if he condusted the studies or was involved in designing them?

More later.
Linda